Haemonetics Corporation Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31)
Haemonetics Corporation (HAE) reported Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) of $2.49 million for the 6-month period ending 2012-09-29, per its 10-Q filed 2012-11-07.
Discontinued › Expense Statement › Income Tax
us-gaap:TaxBenefitFromStockOptionsExercised · last filed 2012-11-07
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2012-09-29 was $1.44M, a 141.28% increase year-over-year.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2012-06-30 was $1.05M, a 194.94% increase year-over-year.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $548.00K, a 464.95% increase year-over-year.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $458.00K, a 88.25% decline year-over-year.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2012 was $1.96M, a 60.37% decline from fiscal 2011.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2011 was $4.94M, a 85.06% increase from fiscal 2010.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2010 was $2.67M, a 20.72% decline from fiscal 2009.
- Haemonetics Corporation tax benefit from stock options exercised (deprecated 2012-01-31) for fiscal 2009 was $3.37M.
| Period end | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 3 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 6 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 9 month | Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-09-29 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-07 | $2.49M 10-Q · filed 2012-11-07 | $3.04M derived: sum of 3 quarters · filed 2012-11-07 | $3.49M derived: sum of 4 quarters · filed 2012-11-07 |
| 2012-06-30 | $1.05M 10-Q · filed 2012-08-08 | $1.60M derived: sum of 2 quarters · filed 2012-08-08 | $2.06M derived: sum of 3 quarters · filed 2012-08-08 | $2.65M derived: sum of 4 quarters · filed 2012-11-07 |
| 2012-03-31 | $548.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-22 | $1.01M derived: sum of 2 quarters · filed 2012-05-22 | $1.60M derived: sum of 3 quarters · filed 2012-11-07 | $1.96M 10-K · filed 2012-05-22 |
| 2011-12-31 | $458.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-06 | $1.05M derived: sum of 2 quarters · filed 2012-11-07 | $1.41M 10-Q · filed 2012-02-06 | $1.51M derived: sum of 4 quarters · filed 2012-11-07 |
| 2011-10-01 | $596.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-07 | $952.00K 10-Q · filed 2012-11-07 | $1.05M derived: sum of 3 quarters · filed 2012-11-07 | $4.95M derived: sum of 4 quarters · filed 2012-11-07 |
| 2011-07-02 | $356.00K 10-Q · filed 2012-08-08 | $453.00K derived: sum of 2 quarters · filed 2012-08-08 | $4.35M derived: sum of 3 quarters · filed 2012-08-08 | $4.76M derived: sum of 4 quarters · filed 2012-08-08 |
| 2011-04-02 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-22 | $4.00M derived: sum of 2 quarters · filed 2012-05-22 | $4.40M derived: sum of 3 quarters · filed 2012-05-22 | $4.94M 10-K · filed 2012-05-22 |
| 2011-01-01 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-06 | $4.31M derived: sum of 2 quarters · filed 2012-02-06 | $4.84M 10-Q · filed 2012-02-06 | $6.31M derived: sum of 4 quarters · filed 2012-05-22 |
| 2010-10-02 | $408.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-03 | $946.00K 10-Q · filed 2011-11-03 | $2.41M derived: sum of 3 quarters · filed 2012-05-22 | $3.44M derived: sum of 4 quarters · filed 2012-05-22 |
| 2010-07-03 | $538.00K 10-Q · filed 2011-08-10 | $2.00M derived: sum of 2 quarters · filed 2012-05-22 | $3.03M derived: sum of 3 quarters · filed 2012-05-22 | $3.04M derived: sum of 4 quarters · filed 2012-05-22 |
| 2010-04-03 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-22 | $2.49M derived: sum of 2 quarters · filed 2012-05-22 | $2.50M derived: sum of 3 quarters · filed 2012-05-22 | $2.67M 10-K · filed 2012-05-22 |
| 2009-12-26 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-02-08 | $1.03M derived: sum of 2 quarters · filed 2011-02-08 | $1.21M 10-Q · filed 2011-02-08 | |
| 2009-09-26 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2010-11-10 | $177.00K 10-Q · filed 2010-11-10 | ||
| 2009-06-27 | $173.00K 10-Q · filed 2010-08-11 | |||
| 2009-03-28 | $3.37M 10-K · filed 2011-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |